Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIQ

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIQ - Post by User

IMV Inc > Little perspective...
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(25)
•••
Comment by pp19888on Jul 22, 2020 9:35pm
230 Views
Post# 31305430

RE:Little perspective...

RE:Little perspective...Just simply compared IMV with another Nova Scotia based Canadian company called Sona nanotech which is now 500M company just on basis of covid test kit development alone. It's market is now higher than IMV, so common IMV is not worth 500M? I think if sona is valued at 500M then IMV should be worth 2-3B. Once this price manipulation done this thing is going parabolic imo. In at 2 and just holding as it got good pipeline, covid is just a trump card.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities